Open AccessSubstantiation of Using Pimecrolimus 1% Cream in Proactive Therapy of Children with Atopic Dermatitis
Author(s) -
Н. Н. Мурашкин,
Р. А. Иванов,
Э. Т. Амбарчян,
Р. В. Епишев,
А. И. Материкин,
Л. А. Опрятин,
Alena A. Savelova
Publication year - 2021
Publication title -
voprosy sovremennoj pediatrii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v20i5.2310
Subject(s) - pimecrolimus , atopic dermatitis , medicine , dermatology , population , calcineurin , environmental health , surgery , transplantation
Atopic dermatitis (AtD) is multifactorial inflammatory skin disease with high prevalence in pediatric population. It is crucial to implement long-term maintenance therapy to prevent AtD exacerbations according to current clinical guidelines and expert reports. The article summarizes the results of the major studies on using pimecrolimus 1% cream. Its efficacy and safety in long-term proactive therapy of children with AtD are presented.